Evidence map›Paper›PMID 31694971›Full record

ArticleJournal of clinical microbiology2019

Significant Improvement in Diagnosis of Hepatitis C Virus Infection by a One-Step Strategy in a Central Laboratory: an Optimal Tool for Hepatitis C Elimination?

Rosa López-Martínez, Andrea Arias-García, Francisco Rodríguez-Algarra, Laura Castellote-Bellés, Ariadna Rando-Segura, Guillermo Tarraso, Elena Vargas-Accarino, Isabel Montserrat-Lloan, Albert Blanco-Grau, Andrea Caballero-Garralda and 7 more

Open access · hybridAbstract read
In one paragraph

Article in Journal of clinical microbiology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
2.1field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 31 citations in OpenAlex.

  1. Article
  2. Observational
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. HCV reflex testing: A single-sample, low-contamination method that improves the diagnostic efficiency of HCV testing among patients in Alberta, Canada.Journal of the Association of Medical Microbiology and Infectious Disease Canada = Journal officiel de l'Association pour la microbiologie medicale et l'infectiologie Canada · 2022
    Article
  12. Review
  13. Article
  14. Utility of the CobasDiagnostics (Basel, Switzerland) · 2021
    Article
  15. [Exploring the health education model for chronic hepatitis C micro-elimination in Guizhou Province from a global perspectives].Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 5 institutions in 2 countries.

Rosa López-MartínezDepartment of Clinical Biochemistry (Clinical Laboratories), University Hospital Vall d'Hebron, Barcelona, Spain.
Andrea Arias-GarcíaDepartment of Clinical Biochemistry (Clinical Laboratories), University Hospital Vall d'Hebron, Barcelona, Spain.
Francisco Rodríguez-AlgarraBlizard Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom.
Laura Castellote-BellésDepartment of Clinical Biochemistry (Clinical Laboratories), University Hospital Vall d'Hebron, Barcelona, Spain.
Ariadna Rando-SeguraPROSICS Barcelona, Microbiology, University Hospital Vall d'Hebron, Barcelona, Spain.
Guillermo TarrasoDepartment of Clinical Biochemistry (Clinical Laboratories), University Hospital Vall d'Hebron, Barcelona, Spain.
Elena Vargas-AccarinoClinical Biochemistry Research Group, Vall d'Hebron Institute of Research (VHIR), Barcelona, Spain.
Isabel Montserrat-LloanDepartment of Haematology and Haemotherapy, University Hospital Vall d'Hebron, Barcelona, Spain.
Albert Blanco-GrauDepartment of Clinical Biochemistry (Clinical Laboratories), University Hospital Vall d'Hebron, Barcelona, Spain.
Andrea Caballero-GarraldaDepartment of Clinical Biochemistry (Clinical Laboratories), University Hospital Vall d'Hebron, Barcelona, Spain.
Roser Ferrer-CostaDepartment of Clinical Biochemistry (Clinical Laboratories), University Hospital Vall d'Hebron, Barcelona, Spain.
Tomas Pumarola-SunyePROSICS Barcelona, Microbiology, University Hospital Vall d'Hebron, Barcelona, Spain.
Maria Buti-FerretDepartment of Internal Medicine and Hepatology, University Hospital Vall d'Hebron, Barcelona, Spain.
Rafael Esteban-MurDepartment of Internal Medicine and Hepatology, University Hospital Vall d'Hebron, Barcelona, Spain.
Josep QuerDepartment of Internal Medicine and Hepatology, University Hospital Vall d'Hebron, Barcelona, Spain.
Ernesto Casis-SaezDepartment of Clinical Biochemistry (Clinical Laboratories), University Hospital Vall d'Hebron, Barcelona, Spain.
Francisco Rodríguez-FríasDepartment of Clinical Biochemistry (Clinical Laboratories), University Hospital Vall d'Hebron, Barcelona, Spain frarodri@vhebron.net.
Vall d'Hebron Hospital Universitari · ESVall d'Hebron Institut de Recerca · ESUniversitat Autònoma de Barcelona · ESCentro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas · ESQueen Mary University of London · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The remarkable effectivity of current antiviral therapies has led to consider the elimination of hepatitis C virus (HCV) infection. However, HCV infection is highly underdiagnosed; therefore, a global strategy for eliminating it requires improving the effectiveness of HCV diagnosis to identify hidden cases. In this study, we assessed the effectiveness of a protocol for HCV diagnosis based on viral load reflex testing of anti-HCV antibody-positive patients (known as one-step diagnosis) by analyzing all diagnostic tests performed by a central laboratory covering an area of 1.5 million inhabitants in Barcelona, Spain, before (83,786 cases) and after (45,935 cases) the implementation of the reflex testing protocol. After its implementation, the percentage of anti-HCV-positive patients with omitted HCV RNA determination remarkably decreased in most settings, particularly in drug treatment centers and primary care settings, where omitted HCV RNA analyses had absolute reductions of 76.4 and 20.2%, respectively. In these two settings, the percentage of HCV RNA-positive patients identified as a result of reflex testing accounted for 55 and 61% of all anti-HCV-positive patients. HCV RNA results were provided in a mean of 2 days. The presence of HCV RNA and age of ≥65 years were significantly associated with advanced fibrosis, assessed using the serological FIB-4 index (odds ratio [OR], 5.92; 95% confidence interval [CI], 3.4 to 10.4). The implementation of viral load reflex testing in a central laboratory is feasible and significantly increases the diagnostic effectiveness of HCV infections, while allowing the identification of underdiagnosed cases.

Indexed as

HepacivirusMolecular Diagnostic TechniquesClinical Decision-MakingClinical Laboratory TechniquesDecision TreesDisease ManagementHepatitis CHumansLiver CirrhosisRNA, ViralSensitivity and SpecificitySpainViral LoadRNA, Viraldiagnosishepatitis C virusone-step diagnosisreflex testingviral load

Identifiers

PMID31694971
PMCPMC6935937
OpenAlexW2985843847

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.